As was recently outlined by the National Institute of Allergy and Infectious Diseases (NIAID) in their pandemic-preparedness plan (P3), research into new technologies is a cornerstone of future ...
Licensing And Collaborative Research Opportunity: The National Institute of Allergy and Infectious Diseases is seeking statements of capability or interest from parties interested in collaborative ...
DoxyPEP is reducing the rate of syphilis and chlamydia but has had little to no effect on gonorrhea and needs close monitoring for antibiotic resistance.